These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway. Xue M; Pang H; Li X; Li H; Pan J; Chen W Cancer Sci; 2016 Jan; 107(1):18-27. PubMed ID: 26544536 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of thymosin β4 in the regulation of epithelial-mesenchymal transformation in urothelial carcinoma. Wang ZY; Zeng FQ; Zhu ZH; Jiang GS; Lv L; Wan F; Dong R; Xiao XY; Xing SA Urol Oncol; 2012; 30(2):167-76. PubMed ID: 20864366 [TBL] [Abstract][Full Text] [Related]
4. Androgen receptor inducing bladder cancer progression by promoting an epithelial-mesenchymal transition. Jitao W; Jinchen H; Qingzuo L; Li C; Lei S; Jianming W; Zhenli G Andrologia; 2014 Dec; 46(10):1128-33. PubMed ID: 24329492 [TBL] [Abstract][Full Text] [Related]
5. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2. Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542 [TBL] [Abstract][Full Text] [Related]
6. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development. Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353 [TBL] [Abstract][Full Text] [Related]
7. miR-451 inhibits invasion and proliferation of bladder cancer by regulating EMT. Zeng T; Peng L; Chao C; Fu B; Wang G; Wang Y; Zhu X Int J Clin Exp Pathol; 2014; 7(11):7653-62. PubMed ID: 25550801 [TBL] [Abstract][Full Text] [Related]
8. MiR-186 suppresses the growth and metastasis of bladder cancer by targeting NSBP1. Yao K; He L; Gan Y; Zeng Q; Dai Y; Tan J Diagn Pathol; 2015 Aug; 10():146. PubMed ID: 26290438 [TBL] [Abstract][Full Text] [Related]
9. Gambogic Acid Improves Cisplatin Resistance of Bladder Cancer Cells through the Epithelial-Mesenchymal Transition Pathway Mediated by the miR-205-5p/ZEB1 Axis. Mei Y; Xu J; Li W; Chen S Ann Clin Lab Sci; 2024 May; 54(3):354-362. PubMed ID: 39048172 [TBL] [Abstract][Full Text] [Related]
10. miR-325-3p Overexpression Inhibits Proliferation and Metastasis of Bladder Cancer Cells by Regulating MT3. Sun S; Liu F; Xian S; Cai D Med Sci Monit; 2020 Jun; 26():e920331. PubMed ID: 32512576 [TBL] [Abstract][Full Text] [Related]
11. Effects of microRNA-135a on the epithelial-mesenchymal transition, migration and invasion of bladder cancer cells by targeting GSK3β through the Wnt/β-catenin signaling pathway. Mao XW; Xiao JQ; Li ZY; Zheng YC; Zhang N Exp Mol Med; 2018 Jan; 50(1):e429. PubMed ID: 29350680 [TBL] [Abstract][Full Text] [Related]
12. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma. Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389 [TBL] [Abstract][Full Text] [Related]
13. microRNA-335 inhibits colorectal cancer HCT116 cells growth and epithelial-mesenchymal transition (EMT) process by targeting Twist1. Wang J; Wang X; Liu F; Fu Y Pharmazie; 2017 Aug; 72(8):475-481. PubMed ID: 29441907 [TBL] [Abstract][Full Text] [Related]
14. Proteasome inhibitor-resistant cells cause EMT-induction via suppression of E-cadherin by miR-200 and ZEB1. Asakura T; Yamaguchi N; Ohkawa K; Yoshida K Int J Oncol; 2015 May; 46(5):2251-60. PubMed ID: 25738863 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of miR-200a suppresses epithelial-mesenchymal transition of liver cancer stem cells. Wang J; Yang X; Ruan B; Dai B; Gao Y; Duan J; Qu S; Tao K; Dou K; Li H Tumour Biol; 2015 Apr; 36(4):2447-56. PubMed ID: 25412960 [TBL] [Abstract][Full Text] [Related]
16. A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer. Hu H; Wang YL; Wang GW; Wong YC; Wang XF; Wang Y; Xu KX Urol Oncol; 2013 Oct; 31(7):1242-53. PubMed ID: 22226665 [TBL] [Abstract][Full Text] [Related]
17. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer. Kong X; Ding X; Li X; Gao S; Yang Q Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542 [TBL] [Abstract][Full Text] [Related]
18. Krüppel-like factor 4 is a novel prognostic predictor for urothelial carcinoma of bladder and it regulates TWIST1-mediated epithelial-mesenchymal transition. Tseng WC; Chuang CW; Yang MH; Pan CC; Tarng DC Urol Oncol; 2016 Nov; 34(11):485.e15-485.e24. PubMed ID: 27519276 [TBL] [Abstract][Full Text] [Related]
19. Differential expression of epithelial and mesenchymal proteins in a panel of prostate cancer cell lines. Murali AK; Norris JS J Urol; 2012 Aug; 188(2):632-8. PubMed ID: 22704442 [TBL] [Abstract][Full Text] [Related]
20. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition. Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]